| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
§
From the Center for Neurovirology and Neurodegenerative
Disorders,*
the Departments of Pathology and Microbiology
and
Medicine,
and the Eppley
Institute for Cancer and Allied Diseases,§
University of Nebraska Medical Center, Omaha, Nebraska; the Division of
Infectious Diseases,¶
Childrens Hospital Los
Angeles, University of Southern California School of Medicine, Los
Angeles, California; the Reed Neurology Research
Institute,||
University of California Los Angeles School
of Medicine, Los Angeles, California; and the Department of
Surgery,**
University of Arizona School of
Medicine, Tucson, Arizona
The numbers of immune-activated brain mononuclear phagocytes (MPs) affect the progression of human immunodeficiency virus (HIV)-1-associated dementia (HAD). Such MPs originate, in measure, from a pool of circulating monocytes. To address the mechanism(s) for monocyte penetration across the blood-brain barrier (BBB), we performed cross-validating laboratory, animal model, and human brain tissue investigations into HAD pathogenesis. First, an artificial BBB was constructed in which human brain microvascular endothelial and glial cells—astrocytes, microglia, and/or monocyte-derived macrophages (MDM)—were placed on opposite sides of a matrix-coated porous membrane. Second, a SCID mouse model of HIV-1 encephalitis (HIVE) was used to determine in vivo monocyte blood-to-brain migration. Third, immunohistochemical analyses of human HIVE tissue defined the relationships between astrogliosis, activation of microglia, virus infection, monocyte brain infiltration, and ß-chemokine expression. The results, taken together, showed that HIV-1-infected microglia increased monocyte migration through an artificial BBB 2 to 3.5 times more than replicate numbers of MDM. In the HIVE SCID mice, a marked accumulation of murine MDM was found in areas surrounding virus-infected human microglia but not MDM. For human HIVE, microglial activation and virus infection correlated with astrogliosis, monocyte transendothelial migration, and ß-chemokine expression. Pure cultures of virus-infected and activated microglia or astrocytes exposed to microglial conditioned media produced significant quantities of ß-chemokines. We conclude that microglial activation alone and/or through its interactions with astrocytes induces ß-chemokine-mediated monocyte migration in HAD.
This article has been cited by other articles:
 |
|
 |
|
  M. Malik, Y.-Y. Chen, M. F. Kienzle, B. E. Tomkowicz, R. G. Collman, and A. Ptasznik Monocyte Migration and LFA-1-Mediated Attachment to Brain Microvascular Endothelia Is Regulated by SDF-1{alpha} through Lyn Kinase J. Immunol., October 1, 2008; 181(7): 4632 - 4637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, J. Sun, and H. Goldstein Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by Lipopolysaccharide J. Virol., August 1, 2008; 82(15): 7591 - 7600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sun, J. H. Zheng, M. Zhao, S. Lee, and H. Goldstein Increased In Vivo Activation of Microglia and Astrocytes in the Brains of Mice Transgenic for an Infectious R5 Human Immunodeficiency Virus Type 1 Provirus and for CD4-Specific Expression of Human Cyclin T1 in Response to Stimulation by Lipopolysaccharides J. Virol., June 1, 2008; 82(11): 5562 - 5572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Ramirez, D. Heilman, B. Morsey, R. Potula, J. Haorah, and Y. Persidsky Activation of Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) Suppresses Rho GTPases in Human Brain Microvascular Endothelial Cells and Inhibits Adhesion and Transendothelial Migration of HIV-1 Infected Monocytes J. Immunol., February 1, 2008; 180(3): 1854 - 1865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Borda, X. Alvarez, M. Mohan, M. S. Ratterree, K. Phillippi-Falkenstein, A. A. Lackner, and B. A. Bunnell Clinical and Immunopathologic Alterations in Rhesus Macaques Affected with Globoid Cell Leukodystrophy Am. J. Pathol., January 1, 2008; 172(1): 98 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Grab, E. Nyarko, N. C. Barat, O. V. Nikolskaia, and J. S. Dumler Anaplasma phagocytophilum-Borrelia burgdorferi Coinfection Enhances Chemokine, Cytokine, and Matrix Metalloprotease Expression by Human Brain Microvascular Endothelial Cells Clin. Vaccine Immunol., November 1, 2007; 14(11): 1420 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K Singh, Y. Jiang, S. Gupta, and E. Benlhabib Effects of chronic ethanol drinking on the blood brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injection Alcohol Alcohol., September 1, 2007; 42(5): 385 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Lehmann, S. Masanetz, S. Kramer, and V. Erfle HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner J. Cell Sci., November 1, 2006; 119(21): 4520 - 4530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Toborek Do not Rho tight junctions (or they become leaky) Blood, June 15, 2006; 107(12): 4581 - 4581. [Full Text] [PDF]
|
|
|
|
|
|
Y. Persidsky, D. Heilman, J. Haorah, M. Zelivyanskaya, R. Persidsky, G. A. Weber, H. Shimokawa, K. Kaibuchi, and T. Ikezu Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE) Blood, June 15, 2006; 107(12): 4770 - 4780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Potula, L. Poluektova, B. Knipe, J. Chrastil, D. Heilman, H. Dou, O. Takikawa, D. H. Munn, H. E. Gendelman, and Y. Persidsky Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis Blood, October 1, 2005; 106(7): 2382 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Uddin, H. H. Garcia, R. H. Gilman, A. E. Gonzalez, and J. S. Friedland Monocyte-Astrocyte Networks and the Regulation of Chemokine Secretion in Neurocysticercosis J. Immunol., September 1, 2005; 175(5): 3273 - 3281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kipnis, H. Avidan, R. R. Caspi, and M. Schwartz Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia PNAS, October 5, 2004; 101(suppl_2): 14663 - 14669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson Role of Microglia in Central Nervous System Infections Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Potter, P. Lemey, G. Achaz, C. B. Chew, A.-M. Vandamme, D. E. Dwyer, and N. K. Saksena HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy J. Leukoc. Biol., September 1, 2004; 76(3): 562 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Argyris, E. Acheampong, G. Nunnari, M. Mukhtar, K. J. Williams, and R. J. Pomerantz Human Immunodeficiency Virus Type 1 Enters Primary Human Brain Microvascular Endothelial Cells by a Mechanism Involving Cell Surface Proteoglycans Independent of Lipid Rafts J. Virol., November 15, 2003; 77(22): 12140 - 12151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Persidsky and H. E. Gendelman Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection J. Leukoc. Biol., November 1, 2003; 74(5): 691 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Garaci, S. Aquaro, C. Lapenta, A. Amendola, M. Spada, S. Covaceuszach, C.-F. Perno, and F. Belardelli Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice PNAS, July 22, 2003; 100(15): 8927 - 8932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Eugenin, M. C. Branes, J. W. Berman, and J. C. Saez TNF-{alpha} Plus IFN-{gamma} Induce Connexin43 Expression and Formation of Gap Junctions Between Human Monocytes/Macrophages That Enhance Physiological Responses J. Immunol., February 1, 2003; 170(3): 1320 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gonzalez, B. H. Rovin, L. Sen, G. Cooke, R. Dhanda, S. Mummidi, H. Kulkarni, M. J. Bamshad, V. Telles, S. A. Anderson, et al. From the Cover: HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels PNAS, October 15, 2002; 99(21): 13795 - 13800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Zink, E. Anderson, J. Boyle, L. Hock, J. Rodriguez-Sierra, H. Xiong, H. E. Gendelman, and Y. Persidsky Impaired Spatial Cognition and Synaptic Potentiation in a Murine Model of Human Immunodeficiency Virus Type 1 Encephalitis J. Neurosci., March 15, 2002; 22(6): 2096 - 2105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Del Corno, Q.-H. Liu, D. Schols, E. de Clercq, S. Gessani, B. D. Freedman, and R. G. Collman HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling Blood, November 15, 2001; 98(10): 2909 - 2916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ghorpade, R. Persidskaia, R. Suryadevara, M. Che, X. J. Liu, Y. Persidsky, and H. E. Gendelman Mononuclear Phagocyte Differentiation, Activation, and Viral Infection Regulate Matrix Metalloproteinase Expression: Implications for Human Immunodeficiency Virus Type 1-Associated Dementia J. Virol., July 15, 2001; 75(14): 6572 - 6583. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Martin, N. Serradji, N. Dereuddre-Bosquet, G. Le Pavec, G. Fichet, A. Lamouri, F. Heymans, J. J. Godfroid, P. Clayette, and D. Dormont PMS-601, a New Platelet-Activating Factor Receptor Antagonist That Inhibits Human Immunodeficiency Virus Replication and Potentiates Zidovudine Activity in Macrophages Antimicrob. Agents Chemother., November 1, 2000; 44(11): 3150 - 3154. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Persidsky, J. Zheng, D. Miller, and H. E. Gendelman Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia J. Leukoc. Biol., September 1, 2000; 68(3): 413 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Limoges, Y. Persidsky, L. Poluektova, J. Rasmussen, W. Ratanasuwan, M. Zelivyanskaya, D. R. McClernon, E. R. Lanier, and H. E. Gendelman Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice Neurology, January 25, 2000; 54(2): 379 - 379. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
